Items where authors include "Boland, E."
Article
Robinson, O., Pini, S., Flemming, K. et al. (9 more authors) (2023) Exploration of pain assessment and management processes in oncology outpatient services with healthcare professionals: a qualitative study. BMJ Open, 13 (12). e078619. ISSN 2044-6055
Robinson, O.C. orcid.org/0000-0002-3171-4407, Pini, S., Flemming, K. et al. (9 more authors) (2023) Exploration of pain assessment and management processes in oncology outpatient services with healthcare professionals: a qualitative study. BMJ Open, 13 (12). e078619. e078619-e078619. ISSN 2044-6055
Ramasamy, M.N., Minassian, A.M., Ewer, K.J. et al. (418 more authors) (2020) Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. The Lancet, 396 (10267). pp. 1979-1993. ISSN 0140-6736
Selvarajah, D. orcid.org/0000-0001-7426-1105, Wilkinson, I.D. orcid.org/0000-0003-2703-6890, Fang, F. et al. (8 more authors) (2019) Structural and functional abnormalities of the primary somatosensory cortex in diabetic peripheral neuropathy: a multimodal MRI study. Diabetes, 68 (4). pp. 796-806. ISSN 0012-1797
Snowden, J.A. orcid.org/0000-0001-6819-3476, Greenfield, D.M., Bird, J.M. et al. (7 more authors) (2017) Guidelines for screening and management of late and long-term consequences of myeloma and its treatment. British Journal of Haematology, 176 (6). pp. 888-907. ISSN 0007-1048
Selvarajah, D. orcid.org/0000-0001-7426-1105, Hughes, T., Reeves, J. et al. (6 more authors) (2016) A preliminary study of brain macrovascular reactivity in impaired glucose tolerance and type-2 diabetes: Quantitative internal carotid artery blood flow using magnetic resonance phase contrast angiography. Diabetes and Vascular Disease Research, 13 (5). pp. 367-372. ISSN 1479-1641
Samuelson, C., O'Toole, L., Boland, E. et al. (4 more authors) (2016) High prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: The case for ‘late effects’ screening and preventive strategies. Hematology, 21 (5). pp. 272-279. ISSN 1024-5332